WEBTOON Entertainment Inc. announced that its President Yongsoo Kim and CFO David J. Lee will participate in several key investor conferences from November to December 2026, including events hosted by J.P. Morgan, Morgan Stanley, UBS, and Raymond James. These presentations will provide updates on the company's growth and innovation in the global entertainment and storytelling platform space. WEBTOON Entertainment is a leader in mobile webcomics and has a large user base, with content partnerships spanning major streaming services and media companies. The UBS and Raymond James presentations will be webcast live and available on the company's investor relations website.
WEBTOON Entertainment Inc. is the subject of upcoming investor conferences, here is Pluang's Media sector market snapshot as of Nov 10, 2026 19:13 WIB: Among 57 priced US Media stocks, 31 rose and 18 fell today. Omnicom Group Inc. (OMC) traded at USD 89.43 with a 1-day gain of +1.05% and a typical hold time of 65 days, while Trump Media and Technology Group Corp (DJT) was priced at USD 4.10, up +0.99% with a shorter hold time of 19 days. IQIYI Inc (IQ) closed at USD 0.92, gaining +0.86%, with a typical hold time of 57 days and a more balanced Pluang order activity of 55% sell to 45% buy.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
